Gary E Rieschel insider trades: Jasper Therapeutics (JSPR) stock purchases
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Gary reports to the SEC
Open-market buys and sales
2 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Jan 27, 2023 | JSPR | ↑ Buy | 2,666,666 | $1.50 | $4.0M | Direct | Apr 11, 2023 (74d) |
| Nov 26, 2010 | THQI | ↑ Buy | 40,000 | $5.15 | $206K | Direct | Nov 30, 2010 (4d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Gary E Rieschel's insider trades
Gary E Rieschel is a 10% owner of Jasper Therapeutics (JSPR). Since Nov 26, 2010, Gary has reported 2 open-market purchases worth $4.2M and no sales on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (7 filings), option exercises (3 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every JSPR insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.